Title |
A review of vagus nerve stimulation as a therapeutic intervention
|
---|---|
Published in |
Journal of Inflammation Research, May 2018
|
DOI | 10.2147/jir.s163248 |
Pubmed ID | |
Authors |
Rhaya L Johnson, Christopher G Wilson |
Abstract |
In this review, we provide an overview of the US Food and Drug Administration (FDA)-approved clinical uses of vagus nerve stimulation (VNS) as well as information about the ongoing studies and preclinical research to expand the use of VNS to additional applications. VNS is currently FDA approved for therapeutic use in patients aged >12 years with drug-resistant epilepsy and depression. Recent studies of VNS in in vivo systems have shown that it has anti-inflammatory properties which has led to more preclinical research aimed at expanding VNS treatment across a wider range of inflammatory disorders. Although the signaling pathway and mechanism by which VNS affects inflammation remain unknown, VNS has shown promising results in treating chronic inflammatory disorders such as sepsis, lung injury, rheumatoid arthritis (RA), and diabetes. It is also being used to control pain in fibromyalgia and migraines. This new preclinical research shows that VNS bears the promise of being applied to a wider range of therapeutic applications. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 33% |
Canada | 1 | 7% |
Curaçao | 1 | 7% |
Germany | 1 | 7% |
Unknown | 7 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 53% |
Scientists | 4 | 27% |
Practitioners (doctors, other healthcare professionals) | 3 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 744 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 101 | 14% |
Student > Master | 81 | 11% |
Researcher | 78 | 10% |
Student > Bachelor | 74 | 10% |
Other | 36 | 5% |
Other | 114 | 15% |
Unknown | 260 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 122 | 16% |
Neuroscience | 90 | 12% |
Engineering | 78 | 10% |
Psychology | 29 | 4% |
Biochemistry, Genetics and Molecular Biology | 28 | 4% |
Other | 118 | 16% |
Unknown | 279 | 38% |